Heyan Biotech
About:
Heyan Biotech provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services.
Website: https://www.huiyan-bio.com/
Top Investors: Greenriver Investment
Description:
Heyan Biotech is a national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery.
Total Funding Amount:
$1.5M
Headquarters Location:
Wuhan, Hubei, China
Founded Date:
2013-09-01
Contact Email:
huiyanbio(AT)126.com
Founders:
Number of Employees:
Last Funding Date:
2020-11-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai